Grail (NASDAQ:GRAL) Sees Large Volume Increase - Here's Why

Grail, Inc. (NASDAQ:GRAL) experienced a notable surge in trading volume on Wednesday, with around 767,467 shares changing hands. This represents a 7% increase compared to the prior session's volume of 716,739 shares. The stock was last priced at $21.69, up from the previous close of $18.49.

Analyst Ratings and Reactions

A series of equities analysts have shared their insights regarding GRAL shares. Guggenheim initiated coverage on Grail on October 17, 2023, issuing a "neutral" rating. Wolfe Research followed suit on November 15, 2023, giving the stock a "peer perform" rating. Additionally, Morgan Stanley began coverage on November 27, 2023, providing an "equal weight" rating with a target price of $16.00 for the stock.

Stock Performance Analysis

The 50-day moving average price for Grail is currently $18.57. The company recently released its quarterly earnings data on November 12, 2023, reporting earnings per share (EPS) of ($3.94) for the quarter. The revenue for this period stood at $28.65 million. Analysts predict that Grail, Inc. will report an EPS of -65.16 for the current year.

Insider Activity

In recent news, CFO Aaron Freidin sold 30,452 shares of Grail on November 18, 2023. The shares were sold at an average price of $14.02, leading to a total transaction value of approximately $426,937. Following this sale, the CFO holds 268,277 shares, with a total value around $3,761,243.54. This transaction reflects a decrease of 10.19% in his holding, as disclosed in SEC filings.

Institutional Transactions

Several institutional investors have made significant movements with their holdings in GRAL. In the fourth quarter, 180 Wealth Advisors LLC acquired a new position in Grail valued at approximately $1,681,000. Douglas Lane & Associates LLC and B & T Capital Management also bought new shares worth $3,034,000 and $387,000, respectively. Other notable investments included FNY Investment Advisers LLC and A. D. Beadell Investment Counsel Inc., both of which purchased stakes valued at around $26,000 and $430,000, respectively.

About Grail, Inc.

Grail, Inc. is a healthcare company focused on developing technologies aimed at the early detection of cancer. The company was founded on September 11, 2015, by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi and is headquartered in Menlo Park, California.

Investment Considerations

Potential investors should take note of ongoing market trends. While Grail holds a "Hold" rating among analysts, top-rated analysts have highlighted five alternative stocks that they believe are more favorable investments at this time. It is advisable to conduct thorough research before making any investment decisions.

Stock, Trading, Analysts